NDC Package 55648-630-07 Adenosine

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55648-630-07
Package Description:
10 SYRINGE, GLASS in 1 CARTON / 2 mL in 1 SYRINGE, GLASS (55648-630-01)
Product Code:
Proprietary Name:
Adenosine
Usage Information:
Intravenous adenosine injection is indicated for the following. Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine administration.  It is important to be sure the adenosine solution actually reaches the systemic circulation (see DOSAGE AND ADMINISTRATION).1Adenosine injection does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm.  In the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine injection administration.
11-Digit NDC Billing Format:
55648063007
NDC to RxNorm Crosswalk:
  • RxCUI: 727355 - adenosine 12 MG in 4 ML Prefilled Syringe
  • RxCUI: 727355 - 4 ML adenosine 3 MG/ML Prefilled Syringe
  • RxCUI: 727355 - adenosine 12 MG per 4 ML Prefilled Syringe
  • RxCUI: 727360 - adenosine 6 MG in 2 ML Prefilled Syringe
  • RxCUI: 727360 - 2 ML adenosine 3 MG/ML Prefilled Syringe
  • Labeler Name:
    Wockhardt Limited
    Sample Package:
    No
    Start Marketing Date:
    07-20-2009
    Listing Expiration Date:
    12-31-2018
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    55648-630-0810 SYRINGE, GLASS in 1 CARTON / 4 mL in 1 SYRINGE, GLASS (55648-630-02)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55648-630-07?

    The NDC Packaged Code 55648-630-07 is assigned to a package of 10 syringe, glass in 1 carton / 2 ml in 1 syringe, glass (55648-630-01) of Adenosine, labeled by Wockhardt Limited. The product's dosage form is and is administered via form.

    Is NDC 55648-630 included in the NDC Directory?

    No, Adenosine with product code 55648-630 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Wockhardt Limited on July 20, 2009 and its listing in the NDC Directory is set to expire on December 31, 2018 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 55648-630-07?

    The 11-digit format is 55648063007. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-255648-630-075-4-255648-0630-07